Pieris Pharmaceuticals, Inc. (PIRS) Financials

PIRS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 59.4 million 28.9 million
2023-06-30 87.5 million 47.0 million
2023-03-31 82.3 million 66.8 million
2022-12-31 95.5 million 67.6 million

PIRS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -9.8 million 966000
2023-06-30 -13.5 million 1.0 million
2023-03-31 -11.0 million 884000
2022-12-31 -13.9 million 949000

PIRS Net Income

No data available :(

PIRS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 44.8 million - 12.3 million
2023-06-30 54.9 million - 12.8 million
2023-03-31 48.4 million - 12.2 million
2022-12-31 59.2 million - 13.1 million

PIRS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 98.9 million
2023-06-30 87.8 million
2023-03-31 74.5 million
2022-12-31 74.2 million

PIRS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 69000 9.6 million 6.8 million -
2023-06-30 67000 14.3 million 3.7 million -
2023-03-31 48000 13.4 million 4.0 million -
2022-12-31 1.0 million 13.4 million 4.0 million -

PIRS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 19.5 million 739000
2023-06-30 20.1 million 725000
2023-03-31 1.9 million 571000
2022-12-31 5.8 million 585000

PIRS

Price: $11.68

52 week price:
0.14
12.00

Earnings Per Share: -0.34 USD

P/E Ratio: -0.54

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 522800

Ebitda: -5.1 million

Market Capitalization: 17.5 million

Links: